Insider transaction feed
Latest SEC Form 4 insider trades with explainable signal scoring.
5,304 transactions Export CSV
Buy volume
$1.23B
2837 buy transactions
Sell volume
$3.58B
2467 sell transactions
Net flow
-$2.34B
Net selling
Total flow
$4.81B
5304 priced transactions
Net insider flow· last 30 days
Buys Sellsnet -$2.71B
Convergence— where independent disclosures line up
View all signals →
| Transaction | Flags | ||||||||
|---|---|---|---|---|---|---|---|---|---|
3d ago Jun 26, 2026 | GAIA, INC | Preston Ned CFO | Buy · A | 76,220 | $2.08 | $158.5K | Neutral+5 | ||
3d ago Jun 26, 2026 | vTv Therapeutics Inc. | BAKER BROS. ADVISORS LP Director | Buy · A | 6,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 26, 2026 | vTv Therapeutics Inc. | BAKER BROS. ADVISORS LP Director | Buy · A | 6,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | Hongchang International Co., Ltd | Lin Zhenzhu Director · 10% Owner | Sell · S | 9,998 | $0.11 | $1.1K | Mild sell-16 | Late | |
3d ago Jun 24, 2026 | Hongchang International Co., Ltd | Lin Zhenzhu Director · 10% Owner | Sell · S | 5,000 | $0.11 | $560 | Mild sell-16 | Late | |
3d ago Jun 23, 2026 | Hongchang International Co., Ltd | Lin Zhenzhu Director · 10% Owner | Sell · S | 1,450 | $0.12 | $174 | Mild sell-16 | Late | |
3d ago Jun 26, 2026 | WORTHINGTON ENTERPRISES, INC. | CHAN KEVIN J Controller | Buy · A | 4 | $56.35 | $245 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | CHAN KEVIN J Controller | Buy · A | 1,030 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 26, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 5 | $56.35 | $277 | Neutral+6 | Deriv | |
3d ago Jun 26, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Sell · F | 1,472 | $56.35 | $82.9K | Neutral+6 | ||
3d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 4,610 | $0.00 | $0 | Neutral+6 | ||
3d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 9,230 | $0.00 | $0 | Neutral+6 | ||
3d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | HAYEK JOSEPH B President & CEO · Director | Buy · A | 19,900 | $0.00 | $0 | Neutral+6 | ||
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Buy · M | 9,500 | $0.00 | $0 | Neutral+1 | 10b5-1Deriv | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 40 | $553.49 | $22.1K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 280 | $552.36 | $154.7K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 400 | $550.79 | $220.3K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 520 | $549.69 | $285.8K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 872 | $548.90 | $478.6K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 452 | $548.13 | $247.8K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 156 | $547.00 | $85.3K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 560 | $545.52 | $305.5K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 439 | $544.18 | $238.9K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,012 | $543.32 | $549.8K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 983 | $542.14 | $532.9K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 2,128 | $541.24 | $1.15M | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,018 | $539.89 | $549.6K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 640 | $538.34 | $344.5K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Buy · M | 9,500 | $135.42 | $1.29M | Neutral+1 | 10b5-1 | |
3d ago Jun 25, 2026 | Navan, Inc. | KOUREY MICHAEL R Director | Buy · A | 9,959 | $0.00 | $0 | Neutral+2 | ||
3d ago Jun 26, 2026 | ACADIA PHARMACEUTICALS INC | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sell · S | 11,421 | $26.08 | $297.9K | Neutral-5 | 10b5-1 | |
3d ago Jun 25, 2026 | QuidelOrtho Corp | WIDDER KENNETH J Director | Buy · A | 1,997 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | QuidelOrtho Corp | WIDDER KENNETH J Director | Buy · A | 6,656 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | QuidelOrtho Corp | WIDDER KENNETH J Director | Buy · A | 15,532 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 1,113 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 822 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 188 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 1,113 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 2,817 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 9,307 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 23,370 | $0.00 | $0 | Mild sell-23 | LateDeriv | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Sell · S | 38,730 | $82.30 | $3.19M | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 1,113 | $48.51 | $54.0K | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 822 | $44.36 | $36.5K | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 188 | $44.36 | $8.3K | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 1,113 | $48.51 | $54.0K | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 2,817 | $44.36 | $125.0K | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 9,307 | $44.36 | $412.9K | Mild sell-23 | Late | |
3d ago Jun 24, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 23,370 | $48.51 | $1.13M | Mild sell-23 | Late | |
3d ago Jun 29, 2026 | CYTOKINETICS, INCORPORATED | Lee Sung EVP, Chief Financial Officer | Buy · M | 823 | $0.00 | $0 | Neutral-11 | Deriv |
